How does distance walked in 6 minutes relate to re- hospitalization? Clinical Problem Solving I Kaylea Kirven Congestive Heart Failure (CHF) in a 79-Year Old Male
Jan 06, 2018
How does distance walked in 6 minutes relate to re-hospitalization?
Clinical Problem Solving IKaylea Kirven
Congestive Heart Failure (CHF) in a 79-Year Old Male
Purpose:•To describe the physical therapy –
▫Examination▫Evaluation▫Plan of care▫Outcomes
•To examine research related to my prognostic question – ▫Is 6-minute walk test distance a prognostic
indicator for re-hospitalization in elderly male patients with severe congestive heart failure?
“Mr. C”•79 year old male•Admitted to hospital presenting with:
▫Abdominal pain ▫Shortness of breath▫Dizziness▫Dysphagia▫Weight gain of 23 lbs
•Past Surgical History:▫CABG x 4 (1981)▫Tonsillectomy
“Mr. C”• Comorbidities:
▫Coronary Artery Disease (CAD)▫Hypertension (HTN)▫Diabetes▫Degenerative Joint Disease▫Chronic Kidney Disease▫Chronic Atrial Fibrillation ▫Previous Stroke (CVA)▫Dementia
• Diagnosis:▫Ingested foreign object▫Congestive Heart Failure (CHF)
Diastolic: NYHA Class I Systolic: NYHA Class IV (Ejection Fraction: 25%)
NYHA Classifications: NYHA Grading
Functional Capacity
Class I:Asymptomatic Dysfunction
No limitations Ordinary physical activity does not cause fatigue, dyspnea, or palpitations
Class II:Mild CHF
Slight limitations Ordinary physical activity results in fatigue, dyspnea, & palpitations
Class III:Moderate CHF
Marked limitations Less than normal physical activity results in symptoms
Class IV:Severe CHF
Unable to carry out any physical activity w/o discomfort Symptoms present @ rest
• Prior Level of Function:▫ Ambulation: RW▫ 24 hr. care
• Review of Systems:▫ Bilateral lower leg edema (2+)▫ Breathing discomfort while
supine w/ head of bed down• Elderly Mobility Scale:
▫ 10/20 “Patient is borderline in terms
of safe mobility & independence in ADLs & requires help with some mobility maneuvers.”
Physical Therapy Evaluation:EVAL
CRITERIAFINDINGS
AROM WFL Shoulder flexion Hip abduction
PROM
MMT Generalized WeaknessDecreased tolerance for activity
Balance:Sitting Static Balance GoodSitting Dynamic Balance Not Tested *Standing Static Balance Fair– with Rolling WalkerStanding Balance with Gait
Fair – with Rolling Walker + CGA
Bed Mobility:Rolling L/R Modified Independence
(HOB raised + Rail utilization)
PT Initial Evaluation: Continued
HOB: Head of BedCGA: Contact Guard Assistance
* Should have been performed
Impairments: Functional Limitations:
•Edema (2+)•Pain (2/10)•Decreased ROM Right > Left•Decreased
Strength•Decreased
Endurance
•Decreased independence
with transfers & ambulation
Disabilities: •Decreased
independence with ADLs
Treatment:Day 1 Day 2 Day 3
Pain (NRPS) 3/10 2/10 1/10Therapeutic Exercises in Sitting(1 set of 10 reps)
- Charleston- Toe Taps- Heel Taps- Seated Marches- Long Arc Quads
SAME SAME
TransfersSit <-> StandWith Rolling Walker
Minimal Assistance x 2
+time & verbal cues
Minimal Assistance x 2
+ verbal cues
Contact Guard Assistance x 1
+ verbal cues
Ambulation 125 ft.(~38 meters)+ RW, CGA, Verbal Cues
Balance Losses: 2
300 ft.(~91 meters)+ RW, CGA, Verbal Cues
Balance Losses: 2
657 ft.(~200 meters)Reached 6 min. of continuous walking + RW, CGA+ 4 Breaks
RW: Rolling Walker LOBs: Loss of BalancesDay 1 Day 2 Day 30
100
200
300
400
500
600
700
Ambulation Distance D
ista
nce
(ft.
)
Patient-Centered Goals: Within 7 days, the patient will…
▫Supine to sit with modified independence ▫Transfer from bed to chair with minimal
assistance + contact guard assistance while holding onto rolling walker
▫Sit to stand with minimal assistance + contact guard assistance
▫Ambulate with contact guard assistance + rolling walker 750 ft. (~228 meters)
PT to see patient 4 x/week
• Treatment Outcomes:▫ Improving & progressing towards goals
• Prognosis:▫Good – Expected to return to previous level of function
Factors Influencing Rehabilitation Potential:1. Medical Condition (-)2. Safety Awareness (-)3. Age (-)4. Comorbidities (-)5. Mental Status (-)6. 24 hr. care @ home (+)7. Supportive Wife (+)
Discharge Site: Home Health Since lives in a 24 hr. care facility
Clinical Question: Is 6-minute walk test distance a
prognostic indicator for re-hospitalization in elderly male patients with severe congestive heart failure?
• Important to consider disease severity & hemodynamic status in CHF patients
• Help identify which CHF patients will likely require intensive therapy?
Promote more effective use of therapies Help optimize treatment in the CHF population
CHF Statistics:•Heart failure is the leading cause of
hospitalization among adults > 65 years old
▫Annually: > 1 million patients are hospitalized for heart
failure [Medicare Expenditure = $17 billion]
▫Within 6 Months of Discharge: > 50% of patients are readmitted to hospital
Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular DysfunctionJournal of the American Medical Association, 1993Bittner et al.
Article 1:
Bittner et al. •Purpose:
▫To study the potential usefulness of the 6-MWT as a prognostic indicator in patients with left ventricular dysfunction
•Methods: Prospective Cohort Study▫898 patients enrolled in the Studies of Left
Ventricular Dysfunction (SOLVD) Registry Ejection Fraction < 0.45 (45%) &/or
radiological evidence of CHF Ischemic Cause or Hypertensive Cause
▫6-MWT performed at baseline▫Follow-up Period: 242 days
Information provided by 895/898 patients
Walkers:N = 833/898 Substudy Patients Age 60 + 12Sex (%) 78% males / 22% femalesEjection Fraction (%) 37 + 14NYHA I (%) 35%NYHA II (%) 47%NYHA III (%) 14%NYHA IV (%) 1%
Bittner et al.
* Note: Most participants were in LOWER NYHA classifications
• Levels:▫Level 1: < 30o meters▫Level 2: 30o – 374.9 meters▫Level 3: 375 – 449.9 meters▫Level 4: > 450 meters
Bittner et al.
While distance was consistent with functional status at the extremes of the NYHA classification system, this graph demonstrates a substantial range in the broad class of mild impairment (NYHA Class II)
80%:Level 1 & Level 2
Bittner et al. Note: Hospitalization for any reason & hospitalization for CHF INCREASED significantly as distance walked decreased
Performance Level 1:
MORE total hospitalizations
MORE hospitalizations for CHF
Prognostic Usefulness of the Six-Minute Walk in Patients With Advanced Congestive Heart Failure Secondary to Ischemic or Nonischemic CardiomyopathyAmerican Journal of Cardiology, 2001Shah et al.
Article 2:
Shah et al. •Purpose:
▫To analyze the ability of the 6-minute walk test to predict death & hospitalization in patients with NYHA Class III or IV CHF
•Methods:▫471 patients (initially) 440 patients
NYHA Class III or IV Ejection Fraction <25%
▫6-MWT protocol was followed Performed at baseline
▫Follow-up Period: @ 52 weeks
Shah et al.
•Results: How Evaluated? ▫Cox Proportional-Hazards Model
Provides an estimate of the hazard ratio & its confidence interval
Hazard Ratios: The chance of events of a hazard occurring at a group relative to the other
Provide confidence in the reliability of the trial data
6-Minute Walk Test Baseline Distance:
Shah et al.
Baseline 6-MWT Distance N = 365Median: 218 meters
Unable to participate in 6-MWT
N = 75
Default Score: 0 meters (Too ill to walk)
NYHA HR SBP DBP
Cox Proportional-Hazards Model: Distance covered on the baseline test significantly predicted re-hospitalization
Shah et al.
HR 95% CI Chi Square p-value Heart failure patients who increase their walking
distance by 100 meters are 0.15 times less likely to be re-admitted to the hospital (or have a 15% lower risk of re-hospitalization)
0.85/100 m increase
+100 meters +150 meters+200 meters
Relative Risk Reduction: 1 – (HR)- Δ distance
17.6% 27.6% 38.4%
365 Baseline Walkers:
•217/365 hospitalized (60%)
•252/365 combined endpoint (69%)
Shah et al.
Limitations: Bittner et al.
Shah et al. & Bittner et al.• 6-MWT’s performed by a variety of staff members
▫ Reproducibility NOT formally assessed• Patients only assessed once (at baseline)• Small percentage of women
▫ May affect generalizability to both genders • Sub-max Test
▫ Patients DO NOT achieve a peak O2 consumption▫ Hard to compare to maximal exercise testing
• Assistive devices utilized? • What were the participants doing between baseline
testing & follow-up?
• Small sample size among NYHA Class III/IV
Conclusions:Bittner et al. Shah et al.• 6-MWT distance strongly
& independently predictshospitalization rates among NYHA Class I & II CHF patients
• Hospitalization during follow-up was lower▫Fewer severe heart
failure patients EF of 0.45 or less
• Baseline distance walked significantly predicts hospitalization in patients with advanced CHF
• Higher hospitalization rate during follow-up▫Participants had Severe
CHF EF of 0.25 or less
Baseline distancewalked is inversely
related to NYHA Class
How Does This Research Relate to My Patient?
• Article 2 (Shah et al.) relates better to my patient▫ Mr. C met all inclusion criteria
NYHA Class III/IV Ejection Fraction < 25%
• Mr. C walked 200 meters (657 ft.) in 6 minutes▫ First Study: Performance Level 1 (< 300 meters)▫ Second Study: Shy of Median Distance Walked (218
meters)
= His distance walked IS a prognostic indicator for his risk of re-hospitalization
(Actually re-admitted 3 months after I saw him)
In the Future:
1. Do changes in test performance over a 1-month period add further prognostic information? If so,
what change from baseline is clinically significant for a better prognosis?
2. Utilize the 6-MWT to develop/monitor rehabilitation & progression
3. If a patient is too ill to walk, what else can be used to determine exercise capacity?
Conclusion:•Simple, non-invasive method to:
▫Risk-stratify patients with CHF
•Objective measure to:▫Guide clinical judgment & management of
CHF patients
•Safer alternative to cardiopulmonary exercise testing ▫Most CHF patients are unable to perform a
maximal symptom-limited exercise test▫Correlates better with daily activity effort
References:• Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI,
et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. Jama. 1993;270(14):1702-7.
• Pollentier B, Irons SL, Benedetto CM, Dibenedetto AM, Loton D, Seyler
RD, et al. Examination of the six minute walk test to determine functional capacity in people with chronic heart failure: a systematic review. Cardiopulmonary physical therapy journal. 2010;21(1):13-21.
• Shah MR, Hasselblad V, Gheorghiade M, Adams KF, Jr., Swedberg K, Califf RM, et al. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. The American journal of cardiology. 2001;88(9):987-93.
Questions?